Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2005
05/24/2005US6897050 Desaturase genes and their use
05/24/2005US6897041 For treating/preventing staphylococcal infections; transcription regulators; ion exchange resins; bacteriophages; genetic engineering/cloning
05/24/2005US6896907 Use of bioactive fraction from cow urine distillate (‘go-mutra’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
05/24/2005US6896901 Controlling or preventing cognitive dysfunction, hyperglycemia and some infective conditions of the skin in mammals by administering pharmaceutically acceptable effective amount of gugulipid
05/24/2005US6896900 β-L-2'-deoxy-nucleosides for the treatment of HIV infection
05/24/2005US6896888 Comprises Bacillus Calmette-Guerin (BCG) formulated with keratolytic agent (salicyclic acid) for topical application
05/24/2005US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
05/24/2005US6896882 Breaking peptidoglycans in cell wall; destroying genomes
05/24/2005CA2326076C Novel macrolides
05/24/2005CA2315408C A double capsule for the administration of active principles in multiple therapies
05/24/2005CA2133316C In vitro generation of human dendritic cells and uses thereof
05/24/2005CA2123875C Hepatitis-c virus testing
05/19/2005WO2005044823A2 Polymorphous forms of rifaximin as antibiotics
05/19/2005WO2005025583A3 Tlr7 ligands for the treatment of hepatitis c
05/19/2005WO2005024025A8 Polyene polyketides and methods of production
05/19/2005WO2005021575A3 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
05/19/2005WO2005017093A8 Polypeptides of streptococcus pyogenes
05/19/2005WO2004098636A3 Vaccinating against infectious diseases using proteosomes
05/19/2005WO2003105767A8 Antifungal parenteral products
05/19/2005WO2003093290A8 Nucleoside derivatives for treating hepatitis c virus infection
05/19/2005WO2003092592A3 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005US20050108785 Using nuclear transplantation as tool in generating transgenic cells for treatment and prevention of liver, nervous system, cardiovascular and bone disorders; regenerative medicine
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107477 Synthetic method and novel chemical compounds
05/19/2005US20050107474 Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents
05/19/2005US20050107472 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
05/19/2005US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto
05/19/2005US20050107435 antibiotics such as (5S,5S')-N-(3-{4'-[5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2,2'-difluoro-biphenyl-4-yl}-2-oxo-oxazolidin-5-ylmethyl)-acetamide, used for treating a bacterial infections in mammals
05/19/2005US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders
05/19/2005US20050107424 8-Azabicyclo[3.2.1]octane derivatives of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridines, used for modulating chemokine CCR5 receptors for treating retroviral infections and inflammatory diseases
05/19/2005US20050107423 Quinolone antibiotics such as 1-Cyclopropyl-6-fluoro-7-(4-hydroxy-hexahydro-cyclopenta[c]pyrrol-2-yl)-8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, used for treating gramnegative or grampositive bacterial infection in mammals
05/19/2005US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
05/19/2005US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases
05/19/2005US20050107403 Carbonylpyridine or carbonylpyrimindine compounds containing another nitrogen containing ring; useful in the treatment of inflammatory, metabolic or malignant conditions
05/19/2005US20050107400 4-[2-(4-Fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-2-pyridinamine, used for the prophylaxis or treatment of herpes viral infections in humans
05/19/2005US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC
05/19/2005US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators
05/19/2005US20050107370 Pyrrole derivatives as antimycobacterial compounds
05/19/2005US20050107367 2-(morpholin-4-yl)-6-phenyl-thiopyran-4-one; treating diseases which are retroviral mediated or ameliorated by the inhibition of DNA-PK
05/19/2005US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists
05/19/2005US20050107344 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin
05/19/2005US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease
05/19/2005US20050107326 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells
05/19/2005US20050107304 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
05/19/2005US20050107303 Health feed
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107291 Compositions and methods for treating or preventing diseases of body passageways
05/19/2005US20050107289 Anti-microbial peptides and compositions
05/19/2005US20050107288 e.g. (S)-2-(3,5-Difluorophenyl)-1-((3S,7S,13S,16S,19S)-13,16,17-trimethyl-2,6,12,15,18-pentaoxo-5-oxa-1,11,14,17-tetraaza-tricyclo[17.3.0.07,11]docos-3-ylcarbamoyl)-ethylammonium 2,2,2-trifluoroacetate
05/19/2005US20050107277 Polyalkylene polymer compounds and uses thereof
05/19/2005US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
05/19/2005US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
05/19/2005US20050106691 Process for the production of ramoplanin-like amide derivatives
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106648 Immmunoglobulin specific to staphylococcal surface protein for use in diagnosis and prevention of bacterial infection; vaccine development; immunotherapy
05/19/2005US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease
05/19/2005US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders
05/19/2005US20050106555 Method of screening for potential anti-bacterial agents
05/19/2005US20050106235 Nsaid formulation comprising a granular composition and an extra-granular composition
05/19/2005US20050106212 Using electrochemical mixture of metal compound and bioactive material; contacting substrate
05/19/2005US20050106191 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
05/19/2005US20050106181 Capsular polysaccharide solubilisation and combination vaccines
05/19/2005US20050106180 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
05/19/2005US20050106175 Genetic engineering; gene mutant ; reduced virulence of rodent bone marrow macrophages
05/19/2005US20050106162 Immunisation against chlamydia trachomatis
05/19/2005US20050106161 Vaccine ; human leukemia, lymphoma virus
05/19/2005US20050106149 Antibodies abolish prion propagation and remote clearance of infectivity
05/19/2005US20050106143 Collapsin response mediator protein; measurement of gene expression
05/19/2005US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof
05/19/2005US20050106136 Controlling capilalries, blood vessels in eye; vision defects
05/19/2005US20050106133 Containing lactobacillus; storage stability
05/19/2005DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes
05/19/2005CA2545157A1 Disinfecting composition and methods of making and using same
05/19/2005CA2543485A1 Use of interferon-tau in medicine
05/19/2005CA2543116A1 Methods for preparing 7-(2'-substituted-.szlig.-d-ribofuranosyl)-4-(nr2r3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
05/19/2005CA2543013A1 Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)
05/19/2005CA2542835A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
05/18/2005EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/18/2005EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
05/18/2005EP1530569A2 Pyridyl substituted heterocycles useful for treating or preventing hcv infection
05/18/2005EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
05/18/2005EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway
05/18/2005EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation
05/18/2005EP1530473A2 Regulation of erythrocyte apoptosis
05/18/2005EP1530427A1 The use of fermented wheat-germ in the feeding and veterinary practice
05/18/2005EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
05/18/2005EP1392290B1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases
05/18/2005EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
05/18/2005EP1263724B1 Novel compounds
05/18/2005EP1100461B1 Vaccine for poultry
05/18/2005EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3
05/18/2005EP1007058B1 Use of (n)-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
05/18/2005EP0820461B1 Aryl-ester phosphoramidate derivatives of 2',3'-didehydronucleosides
05/18/2005EP0584348B1 Genetic vaccine for immunodeficiency viruses
05/18/2005CN1617877A Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
05/18/2005CN1617875A Crystalline cefdinir potassium dihydrate
05/18/2005CN1617862A Novel 1, 2, 4-thiadiazole derivatives as melanocortin receptor modulators
1 ... 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 ... 1798